Cardiac conduction improvement in two heterozygotes for primary carnitine deficiency on L-carnitine supplementation.

Sarafoglou, K; Tridgell, A H C; Bentler, K; Redlinger-Grosse, K; Berry, S A; Schimmenti, L A

Sarafoglou, K; Tridgell, A H C; Bentler, K; Redlinger-Grosse, K; Berry, S A; Schimmenti, L A.

Affiliation

Sarafoglou K; Department of Pediatrics, Division of Genetics and Metabolism, Institute of Human Genetics, University of Minnesota, Minneapolis, MN, USA. saraf010@umn.edu

Clin Genet ; 78(2): 191-4, 2010 Aug.

Article in En | MEDLINE | ID: mdl-20095986

Subject(s)

Carnitine/deficiency; Carnitine/pharmacology; Dietary Supplements; Heart Conduction System/drug effects; Heart Conduction System/physiopathology; Heterozygote; Carnitine/administration & dosage; Female; Humans; Infant, Newborn; Male; Middle Aged; Pregnancy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Carnitine / Dietary Supplements / Heart Conduction System / Heterozygote Type of study: Prognostic_studies Limits: Female / Humans / Male / Middle aged / Newborn / Pregnancy Language: En Year: 2010 Type: Article

Fulltext

XML

PubMed Links

Search on Google